Healthtech Patents

Our healthcare team is led by Dr Seán Klinkradt, who has a PhD in neuroscience and is ranked in the 2023 IAM Patent 1000 as a Recommended Individual, recognised for utilising “his extensive academic background in biochemistry and neuroscience to safeguard his patrons’ intangible assets”. Principal Martin Earley and Senior Associate Warren Chandler add further breadth and depth of expertise to the team, having both spent several years as Patent Examiners at IP Australia reviewing patents in the chemical and pharmaceutical industries. Warren also brings the experience gained during seven years at the CSIRO, where he worked across a range of chemical fields.

The depth of this expertise greatly enhances our ability to assess the merits of a client’s patent application, and to provide commercially astute advice to ensure the successful commercialisation of a client’s IP.

Clients range from start-ups to small research groups, universities and research institutions, as well as SMEs and large corporates. The industries in which we advise clients include:

  • Medical Devices
  • Chemistry
  • Pharmaceuticals
  • Biochemistry
  • Vet Science
  • Biotechnology

In addition to their IP expertise, a number of our attorneys also have prior experience working in the engineering industry. They pride themselves on their ability to understand complex technologies, employing their firsthand understanding of the commercial drivers at the heart of clients’ businesses, and the integral role of IP in their commercial success.

For expert advice on protecting your IP and maximising your means of commercialisation, contact our team of specialists today.

Related Articles

Innovate Boldly. Protect Strategically.

Connect with us
Baxter IP, Patent & Trade Mark Attorneys is a member of:
Copyright 2023 © Baxter IP, Patent & Trade Mark Attorneys